L. Castera, A. Sabbagh, and C. Dehainault, MDM2 as a Modifier Gene in Retinoblastoma, JNCI Journal of the National Cancer Institute, vol.102, issue.23, pp.1805-1808, 2010.
DOI : 10.1093/jnci/djq416

D. Comings, A General Theory of Carcinogenesis, Proceedings of the National Academy of Sciences, vol.70, issue.12, pp.3324-3328, 1973.
DOI : 10.1073/pnas.70.12.3324

S. Friend, R. Bernards, and S. Rogelj, A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma, Nature, vol.4, issue.6089, pp.643-646, 1986.
DOI : 10.1038/323643a0

C. Houdayer, M. Gauthier-villars, and A. Lauge, mutations by DHPLC and QMPSF, Human Mutation, vol.52, issue.2, pp.193-202, 2004.
DOI : 10.1002/humu.10303

M. Jonkman, H. Scheffer, and R. Stulp, Revertant Mosaicism in Epidermolysis Bullosa Caused by Mitotic Gene Conversion, Cell, vol.88, issue.4, pp.543-551, 1997.
DOI : 10.1016/S0092-8674(00)81894-2

A. Knudson and . Jr, Mutation and Cancer: Statistical Study of Retinoblastoma, Proceedings of the National Academy of Sciences, vol.68, issue.4, pp.820-823, 1971.
DOI : 10.1073/pnas.68.4.820

D. Rushlow, B. Piovesan, and K. Zhang, mutations in families with retinoblastoma, Human Mutation, vol.102, issue.5, pp.842-851, 2009.
DOI : 10.1002/humu.20940

K. Sippel, R. Fraioli, and G. Smith, Frequency of Somatic and Germ-Line Mosaicism in Retinoblastoma: Implications for Genetic Counseling, The American Journal of Human Genetics, vol.62, issue.3, pp.610-619, 1998.
DOI : 10.1086/301766

M. Taylor, C. Dehainault, and L. Desjardins, Genotype???phenotype correlations in hereditary familial retinoblastoma, Human Mutation, vol.41, issue.3, pp.284-293, 2007.
DOI : 10.1002/humu.20443

X. Xu, Y. Fang, and T. Lee, Retinoblastoma Has Properties of a Cone Precursor Tumor and Depends Upon Cone-Specific MDM2 Signaling, Cell, vol.137, issue.6, pp.1018-1031, 2009.
DOI : 10.1016/j.cell.2009.03.051

R. 1. Knudson and A. Jr, Mutation and Cancer: Statistical Study of Retinoblastoma, Proceedings of the National Academy of Sciences, vol.68, issue.4, pp.820-823, 1971.
DOI : 10.1073/pnas.68.4.820

D. Comings, A General Theory of Carcinogenesis, Proceedings of the National Academy of Sciences, vol.70, issue.12, pp.3324-3328, 1973.
DOI : 10.1073/pnas.70.12.3324

J. Toguchida, T. Mcgee, and J. Paterson, Complete Genomic Sequence of the Human Retinoblastoma Susceptibility Gene, Genomics, vol.17, issue.3, pp.535-543, 1993.
DOI : 10.1006/geno.1993.1368

S. Friend, R. Bernards, and S. Rogelj, A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma, Nature, vol.4, issue.6089, pp.643-646, 1986.
DOI : 10.1038/323643a0

J. Harbour, Molecular Basis of Low-Penetrance Retinoblastoma, Archives of Ophthalmology, vol.119, issue.11, pp.1699-1704, 2001.
DOI : 10.1001/archopht.119.11.1699

M. Taylor, C. Dehainault, and L. Desjardins, Genotype???phenotype correlations in hereditary familial retinoblastoma, Human Mutation, vol.41, issue.3, pp.284-293, 2007.
DOI : 10.1002/humu.20443

T. Nork, G. Poulsen, L. Millecchia, R. Jantz, and R. Nickells, p53 Regulates Apoptosis in Human Retinoblastoma, Archives of Ophthalmology, vol.115, issue.2, pp.213-219, 1997.
DOI : 10.1001/archopht.1997.01100150215011

Y. Guo, S. Pajovic, and B. Gallie, Expression of p14ARF, MDM2, and MDM4 in human retinoblastoma, Biochemical and Biophysical Research Communications, vol.375, issue.1, pp.1-5, 2008.
DOI : 10.1016/j.bbrc.2008.07.055

A. Shvarts, M. Bazuine, and P. Dekker, Isolation and Identification of the Human Homolog of a New p53-Binding Protein, Mdmx, Genomics, vol.43, issue.1, pp.34-42, 1997.
DOI : 10.1006/geno.1997.4775

N. Laurie, S. Donovan, and C. Shih, Inactivation of the p53 pathway in retinoblastoma, Nature, vol.11, issue.7115, pp.61-66, 2006.
DOI : 10.1038/nature05194

D. Haines, The mdm2 Proto-Oncogene, Leukemia & Lymphoma, vol.41, issue.3-4, pp.3-4227, 1997.
DOI : 10.1016/0968-0004(94)90020-5

R. Honda, H. Tanaka, and H. Yasuda, Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53, FEBS Letters, vol.7, issue.1, pp.25-27, 1997.
DOI : 10.1016/S0014-5793(97)01480-4

P. Sdek, H. Ying, and D. Chang, MDM2 Promotes Proteasome-Dependent Ubiquitin-Independent Degradation of Retinoblastoma Protein, Molecular Cell, vol.20, issue.5, pp.699-708, 2005.
DOI : 10.1016/j.molcel.2005.10.017

C. Uchida, S. Miwa, and K. Kitagawa, Enhanced Mdm2 activity inhibits pRB function via ubiquitin-dependent degradation, The EMBO Journal, vol.6, issue.1
DOI : 10.1038/ncb1101-973

C. Brooks, M. Li, and W. Gu, Mechanistic Studies of MDM2-mediated Ubiquitination in p53 Regulation, Journal of Biological Chemistry, vol.282, issue.31, pp.22804-22815, 2007.
DOI : 10.1074/jbc.M700961200

G. Bond, W. Hu, and E. Bond, A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in Humans, Cell, vol.119, issue.5, pp.591-602, 2004.
DOI : 10.1016/j.cell.2004.11.022

G. Bougeard, S. Baert-desurmont, and I. Tournier, Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome, Journal of Medical Genetics, vol.43, issue.6, pp.531-533, 2006.
DOI : 10.1136/jmg.2005.037952
URL : https://hal.archives-ouvertes.fr/inserm-00128004

N. Laird, S. Horvath, and X. Xu, Implementing a unified approach to family-based tests of association, Genetic Epidemiology, vol.42, issue.S1, pp.36-42, 2000.
DOI : 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.0.CO;2-M

S. Horvath, X. Xu, and N. Laird, The family based association test method: strategies for studying general genotype???phenotype associations, European Journal of Human Genetics, vol.9, issue.4, pp.301-306, 2001.
DOI : 10.1038/sj.ejhg.5200625

R. Spielman, R. Mcginnis, and W. Ewens, Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM), Am J Hum Genet, vol.52, issue.3, pp.506-516, 1993.

Z. Hu, J. G. Wang, L. Chen, F. Wang, X. Shen et al., MDM2 Promoter Polymorphism SNP309 Contributes to Tumor Susceptibility: Evidence from 21 Case-Control Studies, Cancer Epidemiology Biomarkers & Prevention, vol.16, issue.12, pp.2717-2723, 2007.
DOI : 10.1158/1055-9965.EPI-07-0634

D. Kulkarni, A. Vazquez, and B. Haffty, A polymorphic variant in human MDM4 associates with accelerated age of onset of estrogen receptor negative breast cancer, Carcinogenesis, vol.30, issue.11, pp.1910-1915, 2009.
DOI : 10.1093/carcin/bgp224

G. Atwal, T. Kirchhoff, and E. Bond, Altered tumor formation and evolutionary selection of genetic variants in the human MDM4 oncogene, Proceedings of the National Academy of Sciences, vol.106, issue.25, pp.10236-10241, 2009.
DOI : 10.1073/pnas.0901298106

F. Toledo and G. Wahl, Regulating the p53 pathway: in vitro hypotheses, in vivo veritas, Nature Reviews Cancer, vol.55, issue.12, pp.909-923, 2006.
DOI : 10.1002/gcc.20310

H. Dimaras, V. Khetan, and W. Halliday, Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma, Human Molecular Genetics, vol.17, issue.10, pp.1363-1372, 2008.
DOI : 10.1093/hmg/ddn024

M. Pickering and T. Kowalik, Rb inactivation leads to E2F1-mediated DNA double-strand break accumulation, Oncogene, vol.8, issue.5, pp.746-755, 2006.
DOI : 10.1016/S1097-2765(02)00520-8

L. Zheng, A. Flesken-nikitin, P. Chen, and W. Lee, Deficiency of Retinoblastoma gene in mouse embryonic stem cells leads to genetic instability, Cancer Res, vol.62, issue.9, pp.2498-2502, 2002.

X. Xu, Y. Fang, and T. Lee, Retinoblastoma Has Properties of a Cone Precursor Tumor and Depends Upon Cone-Specific MDM2 Signaling, Cell, vol.137, issue.6, pp.1018-1031, 2009.
DOI : 10.1016/j.cell.2009.03.051

A. Ianari, T. Natale, and E. Calo, Proapoptotic Function of the Retinoblastoma Tumor Suppressor Protein, Cancer Cell, vol.15, issue.3, pp.184-94, 2009.
DOI : 10.1016/j.ccr.2009.01.026

L. Vassilev, B. Vu, and B. Graves, In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2, Science, vol.303, issue.5659, pp.844-848, 2004.
DOI : 10.1126/science.1092472

N. Laurie, C. Schin-shih, and M. Dyer, Targeting MDM2 and MDMX in Retinoblastoma, Current Cancer Drug Targets, vol.7, issue.7, pp.689-695, 2007.
DOI : 10.2174/156800907782418266

I. Seyfried, S. Hofbauer, M. Stoecher, R. Greil, and I. Tinhofer, SNP309 as predictor for sensitivity of CLL cells to the MDM2 inhibitor nutlin-3a, Blood, vol.112, issue.5, pp.2168-2169, 2008.
DOI : 10.1182/blood-2008-05-158634

D. H. Abramson, M. E. Mendelsohn, C. A. Servodidio, and T. Tretter, Familial retinoblastoma, where and when?, Acta Ophthalmologica Scandinavica, vol.76, issue.3, pp.334-338, 1998.
DOI : 10.1034/j.1600-0420.1998.760316.x

I. Aerts, P. Leuraud, J. Blais, and A. L. Pouliquen, In vivo efficacy of photodynamic therapy in three new xenograft models of human retinoblastoma, Photodiagnosis and Photodynamic Therapy, vol.7, issue.4, pp.275-283, 2010.
DOI : 10.1016/j.pdpdt.2010.09.003
URL : https://hal.archives-ouvertes.fr/hal-00555070

M. R. Akbari, P. Tonin, W. D. Foulkes, and P. Ghadirian, RAD51C germline mutations in breast and ovarian cancer patients, Breast Cancer Research, vol.39, issue.4, p.404, 2010.
DOI : 10.1038/ng1959

P. Albrecht, B. Ansperger-rescher, A. Schuler, and M. Zeschnigk, Spectrum of gross deletions and insertions in theRB1 gene in patients with retinoblastoma and association with phenotypic expression, Human Mutation, vol.59, issue.5, pp.437-445, 2005.
DOI : 10.1002/humu.20234

J. Alonso, P. Garcia-miguel, J. Abelairas, and M. Mendiola, Spectrum of germline RB1 gene mutations in Spanish retinoblastoma patients: Phenotypic and molecular epidemiological implications, Human Mutation, vol.12, issue.5, pp.412-422, 2001.
DOI : 10.1002/humu.1117

A. C. Antoniou, A. B. Spurdle, O. M. Sinilnikova, and S. Healey, Common Breast Cancer-Predisposition Alleles Are Associated with Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers, The American Journal of Human Genetics, vol.82, issue.4, pp.937-948, 2008.
DOI : 10.1016/j.ajhg.2008.02.008

G. S. Atwal, T. Kirchhoff, E. E. Bond, and M. Montagna, Altered tumor formation and evolutionary selection of genetic variants in the human MDM4 oncogene, Proceedings of the National Academy of Sciences, vol.106, issue.25, pp.10236-10241, 2009.
DOI : 10.1073/pnas.0901298106

G. S. Atwal, R. Rabadan, G. Lozano, and L. C. Strong, An Information-Theoretic Analysis of Genetics, Gender and Age in Cancer Patients, PLoS ONE, vol.91, issue.4, p.1951, 2008.
DOI : 10.1371/journal.pone.0001951.t002

J. L. Bader, R. W. Miller, A. T. Meadows, and L. E. Zimmerman, TRILATERAL RETINOBLASTOMA, The Lancet, vol.316, issue.8194, pp.582-583, 1980.
DOI : 10.1016/S0140-6736(80)92009-7

R. H. Barbosa, F. R. Vargas, F. C. Aguiar, and S. Ferman, Hereditary retinoblastoma transmitted by maternal germline mosaicism, Pediatric Blood & Cancer, vol.129, issue.5, pp.598-602, 2008.
DOI : 10.1002/pbc.21687

B. Bardoni, R. Willemsen, I. J. Weiler, and A. Schenck, NUFIP1 (nuclear FMRP interacting protein 1) is a nucleocytoplasmic shuttling protein associated with active synaptoneurosomes, Experimental Cell Research, vol.289, issue.1, pp.95-107, 2003.
DOI : 10.1016/S0014-4827(03)00222-2

O. Baud, V. Cormier-daire, S. Lyonnet, and L. Desjardins, Dysmorphic phenotype and neurological impairment in 22 retinoblastoma patients with constitutional cytogenetic 13q deletion, Clinical Genetics, vol.52, issue.6, pp.478-482, 1999.
DOI : 10.1002/(SICI)1097-0142(19960315)77:6<1206::AID-CNCR30>3.3.CO;2-Q

G. L. Bond, W. Hu, E. E. Bond, and H. Robins, A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in Humans, Cell, vol.119, issue.5, pp.591-602, 2004.
DOI : 10.1016/j.cell.2004.11.022

G. L. Bond, W. Hu, and A. Levine, A Single Nucleotide Polymorphism in the MDM2 Gene: From a Molecular and Cellular Explanation to Clinical Effect, Cancer Research, vol.65, issue.13, pp.5481-5484, 2005.
DOI : 10.1158/0008-5472.CAN-05-0825

G. L. Bond and A. J. Levine, A single nucleotide polymorphism in the p53 pathway interacts with gender, environmental stresses and tumor genetics to influence cancer in humans, Oncogene, vol.53, issue.9, pp.1317-1323, 2007.
DOI : 10.1002/humu.20277

G. Bougeard, S. Baert-desurmont, I. Tournier, and S. Vasseur, Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome, Journal of Medical Genetics, vol.43, issue.6, pp.531-533, 2006.
DOI : 10.1136/jmg.2005.037952
URL : https://hal.archives-ouvertes.fr/inserm-00128004

R. C. Brennan, S. Federico, C. Bradley, and J. Zhang, Targeting the p53 Pathway in Retinoblastoma with Subconjunctival Nutlin-3a, Cancer Research, vol.71, issue.12, pp.4205-4213, 2011.
DOI : 10.1158/0008-5472.CAN-11-0058

C. L. Brooks, M. Li, and W. Gu, Mechanistic Studies of MDM2-mediated Ubiquitination in p53 Regulation, Journal of Biological Chemistry, vol.282, issue.31, pp.22804-22815, 2007.
DOI : 10.1074/jbc.M700961200

S. Brown, J. Russo, D. Chitayat, and D. Warburton, The 13q-syndrome: the molecular definition of a critical deletion region in band 13q32, Am J Hum Genet, vol.57, issue.4, pp.859-866, 1995.

G. R. Bunin, B. S. Emanuel, A. T. Meadows, and J. D. Buckley, Frequency of 13q Abnormalities Among 203 Patients With Retinoblastoma, JNCI Journal of the National Cancer Institute, vol.81, issue.5, pp.370-374, 1989.
DOI : 10.1093/jnci/81.5.370

L. Calzone, A. Gelay, A. Zinovyev, and F. Radvanyi, A comprehensive modular map of molecular interactions in RB/E2F pathway, Molecular Systems Biology, vol.4, p.173, 2008.
DOI : 10.1016/S0092-8674(00)80625-X

M. Cargill, D. Altshuler, J. Ireland, and P. Sklar, Characterization of singlenucleotide polymorphisms in coding regions of human genes, Nat Genet, vol.22, issue.3, pp.231-238, 1999.

E. A. Carlson and R. J. Desnick, Mutational mosaicism and genetic counseling in retinoblastoma, American Journal of Medical Genetics, vol.132, issue.4, pp.365-381, 1979.
DOI : 10.1002/ajmg.1320040408

L. Cartegni, S. L. Chew, and A. R. Krainer, LISTENING TO SILENCE AND UNDERSTANDING NONSENSE: EXONIC MUTATIONS THAT AFFECT SPLICING, Nature Reviews Genetics, vol.3, issue.4, pp.285-298, 2002.
DOI : 10.1038/nrg775

R. Caselli, C. Speciale, C. Pescucci, and V. Uliana, Retinoblastoma and mental retardation microdeletion syndrome: clinical characterization and molecular dissection using array CGH, Journal of Human Genetics, vol.274, issue.27, pp.535-542, 2007.
DOI : 10.1007/s10038-007-0151-4

L. Castera, C. Dehainault, D. Michaux, and L. Lumbroso-le-rouic, Fine mapping of whole RB1 gene deletions in retinoblastoma patients confirms PCDH8 as a candidate gene for psychomotor delay, European Journal of Human Genetics, vol.170, issue.4, 2012.
DOI : 10.1038/ejhg.2012.186

L. Castera, M. Gauthier-villars, C. Dehainault, and D. Michaux, Mosaicism in clinical practice exemplified by prenatal diagnosis in retinoblastoma, Prenatal Diagnosis, vol.137, issue.11, pp.31-1106, 2011.
DOI : 10.1002/pd.2837

L. Castera, A. Sabbagh, C. Dehainault, and D. Michaux, MDM2 as a Modifier Gene in Retinoblastoma, JNCI Journal of the National Cancer Institute, vol.102, issue.23, pp.1805-1808, 2010.
DOI : 10.1093/jnci/djq416

H. Z. Chen, S. Y. Tsai, and G. Leone, Emerging roles of E2Fs in cancer: an exit from cell cycle control, Nature Reviews Cancer, vol.94, issue.11, pp.785-797, 2009.
DOI : 10.1038/nrc2696

M. Classon and E. Harlow, The retinoblastoma tumour suppressor in development and cancer, Nature Reviews Cancer, vol.2, issue.12, pp.910-917, 2002.
DOI : 10.1038/nrc950

D. E. Comings, A General Theory of Carcinogenesis, Proceedings of the National Academy of Sciences, vol.70, issue.12, pp.3324-3328, 1973.
DOI : 10.1073/pnas.70.12.3324

T. W. Corson and B. L. Gallie, One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma, Genes, Chromosomes and Cancer, vol.43, issue.7, pp.617-634, 2007.
DOI : 10.1002/gcc.20457

J. K. Cowell, B. Bia, and A. Akoulitchev, A novel mutation in the promotor region in a family with a mild form of retinoblastoma indicates the location of a new regulatory domain for the RB1 gene, Oncogene, vol.12, issue.2, pp.431-436, 1996.

I. A. De-la-rosa-velazquez, H. Rincon-arano, L. Benitez-bribiesca, and F. Recillas-targa, Epigenetic Regulation of the Human Retinoblastoma Tumor Suppressor Gene Promoter by CTCF, Cancer Research, vol.67, issue.6, pp.2577-2585, 2007.
DOI : 10.1158/0008-5472.CAN-06-2024

A. H. De-oliveira-reis, I. N. De-carvalho, P. B. De-sousa-damasceno, and S. E. Ferman, Influence of MDM2 and MDM4 on development and survival in hereditary retinoblastoma, Pediatric Blood & Cancer, vol.11, issue.1, pp.39-43, 2012.
DOI : 10.1002/pbc.24014

S. De, Somatic mosaicism in healthy human tissues, Trends in Genetics, vol.27, issue.6, pp.217-223, 2011.
DOI : 10.1016/j.tig.2011.03.002

C. Dehainault, A. Lauge, V. Caux-moncoutier, and S. Pages-berhouet, Multiplex PCR/liquid chromatography assay for detection of gene rearrangements: application to RB1 gene, Nucleic Acids Research, vol.32, issue.18, p.139, 2004.
DOI : 10.1093/nar/gnh137

C. Dehainault, D. Michaux, S. Pages-berhouet, and V. Caux-moncoutier, A deep intronic mutation in the RB1 gene leads to intronic sequence exonisation, European Journal of Human Genetics, vol.34, issue.4, pp.473-477, 2007.
DOI : 10.1038/sj.ejhg.5201787

H. Dimaras, V. Khetan, W. Halliday, and M. Orlic, Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma, Human Molecular Genetics, vol.17, issue.10, pp.1363-1372, 2008.
DOI : 10.1093/hmg/ddn024

H. Dimaras, K. Kimani, E. A. Dimba, and P. Gronsdahl, Retinoblastoma, The Lancet, vol.379, issue.9824, pp.1436-1446, 2012.
DOI : 10.1016/S0140-6736(11)61137-9

F. Doz, R??tinoblastome??: aspects r??cents, Archives de P??diatrie, vol.13, issue.10, pp.1329-1337, 2006.
DOI : 10.1016/j.arcped.2006.06.017

G. J. Draper, B. M. Sanders, and J. E. Kingston, Second primary neoplasms in patients with retinoblastoma, British Journal of Cancer, vol.53, issue.5, pp.661-671, 1986.
DOI : 10.1038/bjc.1986.110

W. Du and J. S. Searle, The Rb Pathway and Cancer Therapeutics, Current Drug Targets, vol.10, issue.7, pp.581-589, 2009.
DOI : 10.2174/138945009788680392

C. Duponchel, C. Di-rocco, M. Cicardi, and M. Tosi, Rapid detection by fluorescent multiplex PCR of exon deletions and duplications in theC1 inhibitorgene of hereditary angioedema patients, Human Mutation, vol.33, issue.1, pp.61-70, 2001.
DOI : 10.1002/1098-1004(2001)17:1<61::AID-HUMU7>3.0.CO;2-9

D. F. Easton, K. A. Pooley, A. M. Dunning, and P. D. Pharoah, Genome-wide association study identifies novel breast cancer susceptibility loci, Nature, vol.70, issue.7148, pp.1087-1093, 2007.
DOI : 10.1038/nature05887

N. A. Ellis, S. Ciocci, and J. German, Back mutation can produce phenotype reversion in Bloom syndrome somatic cells, Human Genetics, vol.108, issue.2, pp.167-173, 2001.
DOI : 10.1007/s004390000447

M. C. Epistolato, V. Disciglio, G. Livide, and P. Berchialla, p53 Arg72Pro and MDM2 309 SNPs in hereditary retinoblastoma, Journal of Human Genetics, vol.16, issue.9, pp.685-686, 2011.
DOI : 10.1038/jhg.2011.82

W. J. Ewens, M. Li, and R. S. Spielman, A Review of Family-Based Tests for Linkage Disequilibrium between a Quantitative Trait and a Genetic Marker, PLoS Genetics, vol.79, issue.9, p.1000180, 2008.
DOI : 10.1371/journal.pgen.1000180

H. C. Fan, W. Gu, J. Wang, and Y. J. Blumenfeld, Non-invasive prenatal measurement of the fetal genome, Nature, vol.142, issue.7407, pp.320-324, 2012.
DOI : 10.1073/pnas.1105422108

S. Fang, R. Krahe, G. Lozano, and Y. Han, Effects of MDM2, MDM4 and TP53 Codon 72 Polymorphisms on Cancer Risk in a Cohort Study of Carriers of TP53 Germline Mutations, PLoS ONE, vol.33, issue.5, p.10813, 2010.
DOI : 10.1371/journal.pone.0010813.s015

R. Fodde and M. Losekoot, Mutation detection by denaturing gradient gel electrophoresis (DGGE), Human Mutation, vol.19, issue.2, pp.83-94, 1994.
DOI : 10.1002/humu.1380030202

L. Foix-l-'helias, I. Aerts, L. Marchand, and L. Lumbroso-le-rouic, Are children born after infertility treatment at increased risk of retinoblastoma?, Human Reproduction, vol.27, issue.7, pp.2186-2192, 2012.
DOI : 10.1093/humrep/des149

G. Francisco, P. R. Menezes, J. Eluf-neto, and R. Chammas, Arg72Pro TP53 polymorphism and cancer susceptibility: A comprehensive meta-analysis of 302 case-control studies, International Journal of Cancer, vol.87, issue.4, pp.920-930, 2011.
DOI : 10.1002/ijc.25710

B. L. Gallie, R. M. Ellsworth, D. H. Abramson, and R. A. Phillips, Retinoma: Spontaneous regression of retinoblastoma or benign manifestation of the mutation?, British Journal of Cancer, vol.45, issue.4, pp.513-521, 1982.
DOI : 10.1038/bjc.1982.87

N. Gonin-laurent, N. S. Hadj-hamou, N. Vogt, and C. Houdayer, RB1 and TP53 pathways in radiation-induced sarcomas, Oncogene, vol.23, issue.41, pp.6106-6112, 2007.
DOI : 10.1038/sj.onc.1210404

M. Gross, H. Hanenberg, S. Lobitz, and R. Friedl, Reverse mosaicism in Fanconi anemia: natural gene therapy via molecular self-correction, Cytogenetic and Genome Research, vol.98, issue.2-3, pp.126-135, 2002.
DOI : 10.1159/000069805

Y. Guo, S. Pajovic, and B. L. Gallie, Expression of p14ARF, MDM2, and MDM4 in human retinoblastoma, Biochemical and Biophysical Research Communications, vol.375, issue.1, pp.1-5, 2008.
DOI : 10.1016/j.bbrc.2008.07.055

D. S. Haines, The mdm2 Proto-Oncogene, Leukemia & Lymphoma, vol.41, issue.3-4, pp.3-4, 1997.
DOI : 10.1016/0968-0004(94)90020-5

R. Hamid, J. D. Cogan, L. K. Hedges, and E. Austin, allele, Human Mutation, vol.91, issue.4, pp.649-654, 2009.
DOI : 10.1002/humu.20922

J. W. Harbour, Molecular Basis of Low-Penetrance Retinoblastoma, Archives of Ophthalmology, vol.119, issue.11, pp.1699-1704, 2001.
DOI : 10.1001/archopht.119.11.1699

R. Honda, H. Tanaka, and H. Yasuda, Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53, FEBS Letters, vol.7, issue.1, pp.25-27, 1997.
DOI : 10.1016/S0014-5793(97)01480-4

S. Horvath, X. Xu, and N. M. Laird, The family based association test method: strategies for studying general genotype???phenotype associations, European Journal of Human Genetics, vol.9, issue.4, pp.301-306, 2001.
DOI : 10.1038/sj.ejhg.5200625

S. Horvath, X. Xu, S. L. Lake, and E. K. Silverman, Family-based tests for associating haplotypes with general phenotype data: Application to asthma genetics, Genetic Epidemiology, vol.67, issue.1, pp.61-69, 2004.
DOI : 10.1002/gepi.10295

C. Houdayer, C. Dehainault, C. Mattler, and D. Michaux, Evaluation of in silico splice tools for decision-making in molecular diagnosis, Human Mutation, vol.24, issue.7, pp.975-982, 2008.
DOI : 10.1002/humu.20765

C. Houdayer, M. Gauthier-villars, L. Castera, and F. Doz, Retinoblastoma - Genetic Counseling and Molecular Diagnosis, Genetic Counseling, 2012.
DOI : 10.5772/34069
URL : http://www.intechopen.com/articles/show/title/retinoblastoma-genetic-counseling-protocols-and-molecular-diagnostic-protocols-

C. Houdayer, M. Gauthier-villars, A. Lauge, and S. Pages-berhouet, mutations by DHPLC and QMPSF, Human Mutation, vol.52, issue.2, pp.193-202, 2004.
DOI : 10.1002/humu.10303

C. Houdayer, V. Moncoutier, J. Champ, and J. Weber, Enhanced Mismatch Mutation Analysis: Simultaneous Detection of Point Mutations and Large Scale Rearrangements by Capillary Electrophoresis, Application to BRCA1 and BRCA2, Methods Mol Biol, vol.653, pp.147-180, 2010.
DOI : 10.1007/978-1-60761-759-4_9

M. T. Howard, N. Malik, C. B. Anderson, and J. L. Voskuil, Attenuation of an amino-terminal premature stop codon mutation in the ATRX gene by an alternative mode of translational initiation, Journal of Medical Genetics, vol.41, issue.12, pp.951-956, 2004.
DOI : 10.1136/jmg.2004.020248

Z. Hu, G. Jin, L. Wang, and F. Chen, MDM2 Promoter Polymorphism SNP309 Contributes to Tumor Susceptibility: Evidence from 21 Case-Control Studies, Cancer Epidemiology Biomarkers & Prevention, vol.16, issue.12, pp.2717-2723, 2007.
DOI : 10.1158/1055-9965.EPI-07-0634

S. Hutchinson, A. Furger, D. Halliday, and D. P. Judge, Allelic variation in normal human FBN1 expression in a family with Marfan syndrome: a potential modifier of phenotype?, Human Molecular Genetics, vol.12, issue.18, pp.2269-2276, 2003.
DOI : 10.1093/hmg/ddg241

A. Ianari, T. Natale, E. Calo, and E. Ferretti, Proapoptotic Function of the Retinoblastoma Tumor Suppressor Protein, Cancer Cell, vol.15, issue.3, pp.184-194, 2009.
DOI : 10.1016/j.ccr.2009.01.026

A. Inacio, A. L. Silva, J. Pinto, and X. Ji, Nonsense Mutations in Close Proximity to the Initiation Codon Fail to Trigger Full Nonsense-mediated mRNA Decay, Journal of Biological Chemistry, vol.279, issue.31, pp.32170-32180, 2004.
DOI : 10.1074/jbc.M405024200

K. B. Jacobs, M. Yeager, W. Zhou, and S. Wacholder, Detectable clonal mosaicism and its relationship to aging and cancer, Nature Genetics, vol.44, issue.6, pp.651-658, 2012.
DOI : 10.1038/nature06258

M. F. Jonkman, H. Scheffer, R. Stulp, and H. H. Pas, Revertant Mosaicism in Epidermolysis Bullosa Caused by Mitotic Gene Conversion, Cell, vol.88, issue.4, pp.543-551, 1997.
DOI : 10.1016/S0092-8674(00)81894-2

D. Kanber, T. Berulava, O. Ammerpohl, and D. Mitter, The Human Retinoblastoma Gene Is Imprinted, PLoS Genetics, vol.17, issue.12, p.1000790, 2009.
DOI : 10.1371/journal.pgen.1000790.s002

M. V. Kato, K. Ishizaki, T. Shimizu, and J. Toguchida, Delayed development of retinoblastoma associated with loss of a maternal allele on chromosome 13, International Journal of Cancer, vol.59, issue.1, pp.3-8, 1995.
DOI : 10.1002/ijc.2910640103

M. V. Kato, T. Shimizu, K. Ishizaki, and A. Kaneko, Loss of heterozygosity on chromosome 17 and mutation of the p53 gene in retinoblastoma, Cancer Letters, vol.106, issue.1, pp.75-82, 1996.
DOI : 10.1016/0304-3835(96)04305-4

M. V. Kato, T. Shimizu, M. Nagayoshi, and A. Kaneko, Genomic imprinting of the human serotonin-receptor (HTR2) gene involved in development of retinoblastoma, Am J Hum Genet, vol.59, issue.5, pp.1084-1090, 1996.

H. Kehrer-sawatzki and D. N. Cooper, Mosaicism in sporadic neurofibromatosis type 1: variations on a theme common to other hereditary cancer syndromes?, Journal of Medical Genetics, vol.45, issue.10, pp.622-631, 2008.
DOI : 10.1136/jmg.2008.059329

S. Y. Kim, S. Yasuda, H. Tanaka, and K. Yamagata, Non-clustered protocadherin, Cell Adhesion & Migration, vol.460, issue.6, pp.97-105, 2011.
DOI : 10.1200/JCO.2008.18.7906

M. Klutz, D. Brockmann, and D. R. Lohmann, A Parent-of-Origin Effect in Two Families with Retinoblastoma Is Associated with a Distinct Splice Mutation in the RB1 Gene, The American Journal of Human Genetics, vol.71, issue.1, pp.174-179, 2002.
DOI : 10.1086/341284

A. G. Knudson and . Jr, Mutation and Cancer: Statistical Study of Retinoblastoma, Proceedings of the National Academy of Sciences, vol.68, issue.4, pp.820-823, 1971.
DOI : 10.1073/pnas.68.4.820

H. Komori, M. Enomoto, M. Nakamura, and R. Iwanaga, Distinct E2F-mediated transcriptional program regulates p14ARF gene expression, The EMBO Journal, vol.18, issue.21, pp.3724-3736, 2005.
DOI : 10.1073/pnas.2536808100

D. A. Kulkarni, A. Vazquez, B. G. Haffty, and E. V. Bandera, A polymorphic variant in human MDM4 associates with accelerated age of onset of estrogen receptor negative breast cancer, Carcinogenesis, vol.30, issue.11, pp.1910-1915, 2009.
DOI : 10.1093/carcin/bgp224

N. M. Laird, S. Horvath, and X. Xu, Implementing a unified approach to family-based tests of association, Genetic Epidemiology, vol.42, issue.S1, pp.36-42, 2000.
DOI : 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.0.CO;2-M

C. C. Laurie, C. A. Laurie, K. Rice, and K. F. Doheny, Detectable clonal mosaicism from birth to old age and its relationship to cancer, Nature Genetics, vol.24, issue.6, pp.642-650, 2012.
DOI : 10.1016/j.ajhg.2010.06.002

N. A. Laurie, S. L. Donovan, C. S. Shih, and J. Zhang, Inactivation of the p53 pathway in retinoblastoma, Nature, vol.11, issue.7115, pp.61-66, 2006.
DOI : 10.1038/nature05194

N. A. Laurie, C. Schin-shih, and M. A. Dyer, Targeting MDM2 and MDMX in Retinoblastoma, Current Cancer Drug Targets, vol.7, issue.7, pp.689-695, 2007.
DOI : 10.2174/156800907782418266

J. F. Lefebvre, E. Vello, B. Ge, and S. B. Montgomery, Genotype-Based Test in Mapping Cis-Regulatory Variants from Allele-Specific Expression Data, PLoS ONE, vol.6, issue.6, p.38667, 2012.
DOI : 10.1371/journal.pone.0038667.s024

K. P. Lele, L. S. Penrose, and H. B. Stallard, Chromosome deletion in a case of retinoblastoma, Annals of Human Genetics, vol.82, issue.2, pp.171-174, 1963.
DOI : 10.1016/S0140-6736(61)91978-X

D. M. Lillington, J. E. Kingston, P. G. Coen, and E. Price, Comparative genomic hybridization of 49 primary retinoblastoma tumors identifies chromosomal regions associated with histopathology, progression, and patient outcome, Genes, Chromosomes and Cancer, vol.343, issue.2, pp.121-128, 2003.
DOI : 10.1002/gcc.10149

D. Lim, S. C. Bowdin, L. Tee, and G. A. Kirby, Clinical and molecular genetic features of Beckwith-Wiedemann syndrome associated with assisted reproductive technologies, Human Reproduction, vol.24, issue.3, pp.741-747, 2009.
DOI : 10.1093/humrep/den406

L. Murphree and A. , Intraocular retinoblastoma: the case for a new group classification, Ophthalmol Clin North Am, vol.18, issue.1, pp.41-53, 2005.

L. Liu, Y. Li, S. Li, and N. Hu, Comparison of next-generation sequencing systems, J Biomed Biotechnol, vol.2012, p.251364, 2012.

W. Liu, L. He, J. Ramirez, and M. J. Ratain, Interactions between MDM2 and TP53 Genetic Alterations, and Their Impact on Response to MDM2 Inhibitors and Other Chemotherapeutic Drugs in Cancer Cells, Clinical Cancer Research, vol.15, issue.24, pp.7602-7607, 2009.
DOI : 10.1158/1078-0432.CCR-09-0890

D. R. Lohmann, RB1 gene mutations in retinoblastoma, Human Mutation, vol.59, issue.4, pp.283-288, 1999.
DOI : 10.1002/(SICI)1098-1004(199910)14:4<283::AID-HUMU2>3.0.CO;2-J

D. R. Lohmann, B. Brandt, W. Hopping, and E. Passarge, Distinct RB1 gene mutations with low penetrance in hereditary retinoblastoma, Human Genetics, vol.94, issue.4, pp.349-354, 1994.
DOI : 10.1007/BF00201591

D. R. Lohmann and B. L. Gallie, Retinoblastoma: Revisiting the model prototype of inherited cancer, American Journal of Medical Genetics, vol.59, issue.1, pp.23-28, 2004.
DOI : 10.1002/ajmg.c.30024

M. Ludwig, A. Katalinic, S. Gross, and A. Sutcliffe, Increased prevalence of imprinting defects in patients with Angelman syndrome born to subfertile couples, Journal of Medical Genetics, vol.42, issue.4, pp.289-291, 2005.
DOI : 10.1136/jmg.2004.026930

A. Mairal, E. Pinglier, E. Gilbert, and M. Peter, Detection of chromosome imbalances in retinoblastoma by parallel karyotype and CGH analyses, Genes, Chromosomes and Cancer, vol.132, issue.4, pp.370-379, 2000.
DOI : 10.1002/1098-2264(200008)28:4<370::AID-GCC2>3.0.CO;2-8

S. Mak, I. Mak, B. L. Gallie, and R. Godbout, Adenovirus-12 genes undetectable in human retinoblastoma, International Journal of Cancer, vol.76, issue.6, pp.697-700, 1982.
DOI : 10.1002/ijc.2910300604

T. Marees, C. J. Dommering, S. M. Imhof, and W. A. Kors, Incidence of retinoblastoma in Dutch children conceived by IVF: an expanded study, Human Reproduction, vol.24, issue.12, pp.3220-3224, 2009.
DOI : 10.1093/humrep/dep335

S. L. Merbs, M. A. Khan, L. Hackler, J. , and V. F. Oliver, Cell-Specific DNA Methylation Patterns of Retina-Specific Genes, PLoS ONE, vol.90, issue.3, p.32602, 2012.
DOI : 10.1371/journal.pone.0032602.s005

D. Mitter, D. Rushlow, I. Nowak, and B. Ansperger-rescher, Identification of a mutation in exon 27 of the RB1 gene associated with incomplete penetrance retinoblastoma, Familial Cancer, vol.59, issue.1, pp.55-58, 2009.
DOI : 10.1007/s10689-008-9198-4

D. Mitter, R. Ullmann, A. Muradyan, and L. Klein-hitpass, Genotype???phenotype correlations in patients with retinoblastoma and interstitial 13q deletions, European Journal of Human Genetics, vol.146, issue.9, pp.947-958, 2011.
DOI : 10.1002/ajmg.1320290403

A. C. Moll, S. M. Imhof, L. M. Bouter, and D. J. Kuik, Second primary tumors in patients with hereditary retinoblastoma: a register-based follow-up study, Int J Cancer, vol.67, issue.4, pp.1945-1994, 1996.

A. C. Moll, S. M. Imhof, A. Y. Meeteren, and M. Boers, At what age could screening for familial retinoblastoma be stopped? A register based study 1945-98, British Journal of Ophthalmology, vol.84, issue.10, pp.1170-1172, 2000.
DOI : 10.1136/bjo.84.10.1170

J. A. Morris, Spontaneous mutation rate in retinoblastoma., Journal of Clinical Pathology, vol.43, issue.6, pp.496-498, 1990.
DOI : 10.1136/jcp.43.6.496

A. L. Murphree and T. J. Triche, An epigenomic mechanism in retinoblastoma: the end of the story?, Genome Medicine, vol.4, issue.2, p.15, 2012.
DOI : 10.1186/1741-7007-9-86

M. A. Musarella and B. L. Gallie, A simplified scheme for genetic counseling in retinoblastoma, J Pediatr Ophthalmol Strabismus, vol.24, issue.3, pp.124-125, 1987.

S. B. Ng, K. J. Buckingham, C. Lee, and A. W. Bigham, Exome sequencing identifies the cause of a mendelian disorder, Nature Genetics, vol.137, issue.1, pp.30-35, 2010.
DOI : 10.1101/gr.078212.108

D. Nittner, I. Lambertz, F. Clermont, and P. Mestdagh, Synthetic lethality between Rb, p53 and Dicer or miR-17???92 in retinal progenitors suppresses retinoblastoma formation, Nature Cell Biology, vol.37, issue.9, 2012.
DOI : 10.1038/ncb2556

T. M. Nork, G. L. Poulsen, L. L. Millecchia, and R. G. Jantz, p53 Regulates Apoptosis in Human Retinoblastoma, Archives of Ophthalmology, vol.115, issue.2, pp.213-219, 1997.
DOI : 10.1001/archopht.1997.01100150215011

Z. Onadim, A. Hogg, P. N. Baird, and J. K. Cowell, Oncogenic point mutations in exon 20 of the RB1 gene in families showing incomplete penetrance and mild expression of the retinoblastoma phenotype., Proceedings of the National Academy of Sciences, vol.89, issue.13, pp.6177-6181, 1992.
DOI : 10.1073/pnas.89.13.6177

M. Orita, Y. Suzuki, T. Sekiya, and K. Hayashi, Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction, Genomics, vol.5, issue.4, pp.874-879, 1989.
DOI : 10.1016/0888-7543(89)90129-8

G. A. Otterson, W. Chen, A. B. Coxon, and S. N. Khleif, Incomplete penetrance of familial retinoblastoma linked to germ-line mutations that result in partial loss of RB function, Proceedings of the National Academy of Sciences, vol.94, issue.22, pp.94-12036, 1997.
DOI : 10.1073/pnas.94.22.12036

G. Ozisik, G. Mantovani, J. C. Achermann, and L. Persani, An Alternate Translation Initiation Site Circumvents an Amino-Terminal DAX1 Nonsense Mutation Leading to a Mild Form of X-Linked Adrenal Hypoplasia Congenita, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.1, pp.417-423, 2003.
DOI : 10.1210/jc.2002-021034

M. Pacal and R. Bremner, Insights from animal models on the origins and progression of retinoblastoma, Curr Mol Med, vol.6, issue.7, pp.759-781, 2006.

W. C. Phelps, K. Munger, C. L. Yee, and J. A. Barnes, Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein, J Virol, vol.66, issue.4, pp.2418-2427, 1992.

M. T. Pickering and T. F. Kowalik, Rb inactivation leads to E2F1-mediated DNA double-strand break accumulation, Oncogene, vol.8, issue.5, pp.746-755, 2006.
DOI : 10.1016/S1097-2765(02)00520-8

G. Pierron, F. Tirode, C. Lucchesi, and S. Reynaud, A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion, Nature Genetics, vol.13, issue.4, pp.461-466, 2012.
DOI : 10.1038/sj.onc.1204437

S. Purcell, K. Neale, L. Todd-brown, and . Thomas, PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses, The American Journal of Human Genetics, vol.81, issue.3, pp.559-575, 2007.
DOI : 10.1086/519795

M. Quail, M. E. Smith, T. D. Coupland, and . Otto, A tale of three next generation sequencing platforms: comparison of Ion torrent, pacific biosciences and illumina MiSeq sequencers, BMC Genomics, vol.13, issue.1, p.341, 2012.
DOI : 10.1186/1471-2164-13-341

C. Quelin, C. Bendavid, C. Dubourg, and C. De-la-rochebrochard, Twelve new patients with 13q deletion syndrome: Genotype???phenotype analyses in progress, European Journal of Medical Genetics, vol.52, issue.1, pp.41-46, 2009.
DOI : 10.1016/j.ejmg.2008.10.002
URL : https://hal.archives-ouvertes.fr/inserm-00353241

B. Rabbani, N. Mahdieh, K. Hosomichi, and H. Nakaoka, Next-generation sequencing: impact of exome sequencing in characterizing Mendelian disorders, Journal of Human Genetics, vol.44, issue.10, 2012.
DOI : 10.1038/ng.2229

S. Richter, K. Vandezande, N. Chen, and K. Zhang, Sensitive and Efficient Detection of RB1 Gene Mutations Enhances Care for Families with Retinoblastoma, The American Journal of Human Genetics, vol.72, issue.2, pp.253-269, 2003.
DOI : 10.1086/345651

N. Risch and K. Merikangas, The Future of Genetic Studies of Complex Human Diseases, Science, vol.273, issue.5281, pp.1516-1517, 1996.
DOI : 10.1126/science.273.5281.1516

J. B. Riviere, B. W. Van-bon, A. Hoischen, and S. S. Kholmanskikh, De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser-Winter syndrome, Nature Genetics, vol.23, issue.4, pp.440-444, 2012.
DOI : 10.1101/gr.6861907

C. Rivolta, T. L. Mcgee, T. R. Frio, and R. V. Jensen, mutations, Human Mutation, vol.419, issue.7, pp.644-653, 2006.
DOI : 10.1002/humu.20325

F. Rodjan, P. De-graaf, H. J. Brisse, and S. Goricke, Trilateral retinoblastoma: neuroimaging characteristics and value of routine brain screening on admission, Journal of Neuro-Oncology, vol.120, issue.3, 2012.
DOI : 10.1007/s11060-012-0922-4

M. W. Ruijs, M. K. Schmidt, H. Nevanlinna, and J. Tommiska, The single-nucleotide polymorphism 309 in the MDM2 gene contributes to the Li???Fraumeni syndrome and related phenotypes, European Journal of Human Genetics, vol.65, issue.1, pp.110-114, 2007.
DOI : 10.1158/0008-5472.CAN-05-3168

D. Rushlow, B. Piovesan, K. Zhang, and N. L. Prigoda-lee, mutations in families with retinoblastoma, Human Mutation, vol.102, issue.5, pp.842-851, 2009.
DOI : 10.1002/humu.20940

R. Sachidanandam, D. Weissman, S. C. Schmidt, and J. M. Kakol, A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms, Nature, vol.7, issue.6822, pp.928-933, 2001.
DOI : 10.1038/35057149

T. Sakai, N. Ohtani, T. L. Mcgee, and P. D. Robbins, Oncogenic germ-line mutations in Sp1 and ATF sites in the human retinoblastoma gene, Nature, vol.353, issue.6339, pp.83-86, 1991.
DOI : 10.1038/353083a0

M. Scarola, S. Schoeftner, C. Schneider, and R. Benetti, miR-335 Directly Targets Rb1 (pRb/p105) in a Proximal Connection to p53-Dependent Stress Response, Cancer Research, vol.70, issue.17, pp.6925-6933, 2010.
DOI : 10.1158/0008-5472.CAN-10-0141

M. W. Schmitt, S. R. Kennedy, J. J. Salk, and E. J. Fox, Detection of ultra-rare mutations by next-generation sequencing, Proceedings of the National Academy of Sciences, vol.109, issue.36, 2012.
DOI : 10.1073/pnas.1208715109

K. Schneiter, J. H. Degnan, C. Corcoran, and X. Xu, EFBAT: exact family-based association tests, BMC Genetics, vol.8, issue.1, p.86, 2007.
DOI : 10.1186/1471-2156-8-86

J. P. Schouten, C. J. Mcelgunn, R. Waaijer, and D. Zwijnenburg, Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification, Nucleic Acids Research, vol.30, issue.12, p.57, 2002.
DOI : 10.1093/nar/gnf056

A. Schuler, S. Weber, M. Neuhauser, and C. Jurklies, Age at diagnosis of isolated unilateral retinoblastoma does not distinguish patients with and without a constitutional RB1 gene mutation but is influenced by a parent-of-origin effect, European Journal of Cancer, vol.41, issue.5, pp.735-740, 2005.
DOI : 10.1016/j.ejca.2004.12.022

P. Sdek, H. Ying, D. L. Chang, and W. Qiu, MDM2 Promotes Proteasome-Dependent Ubiquitin-Independent Degradation of Retinoblastoma Protein, Molecular Cell, vol.20, issue.5, pp.699-708, 2005.
DOI : 10.1016/j.molcel.2005.10.017

I. Seyfried, S. Hofbauer, M. Stoecher, and R. Greil, SNP309 as predictor for sensitivity of CLL cells to the MDM2 inhibitor nutlin-3a, Blood, vol.112, issue.5, pp.2168-2169, 2008.
DOI : 10.1182/blood-2008-05-158634

A. Shvarts, M. Bazuine, P. Dekker, and Y. F. Ramos, Isolation and Identification of the Human Homolog of a New p53-Binding Protein, Mdmx, Genomics, vol.43, issue.1, pp.34-42, 1997.
DOI : 10.1006/geno.1997.4775

K. C. Sippel, R. E. Fraioli, G. D. Smith, and M. E. Schalkoff, Frequency of Somatic and Germ-Line Mosaicism in Retinoblastoma: Implications for Genetic Counseling, The American Journal of Human Genetics, vol.62, issue.3, pp.610-619, 1998.
DOI : 10.1086/301766

R. S. Spielman, R. E. Mcginnis, and W. J. Ewens, Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM), Am J Hum Genet, vol.52, issue.3, pp.506-516, 1993.

S. Strehl, K. Glatt, Q. M. Liu, and H. Glatt, Characterization of Two Novel Protocadherins (PCDH8andPCDH9) Localized on Human Chromosome 13 and Mouse Chromosome 14, Genomics, vol.53, issue.1, pp.81-89, 1998.
DOI : 10.1006/geno.1998.5467

N. Suzuki, T. Ueno, A. Kaneko, and S. Fujii, Analysis of retinoblastoma for human adenovirus type 12 genome, Graefe's Archive for Clinical and Experimental Ophthalmology, vol.82, issue.4, pp.167-170, 1983.
DOI : 10.1007/BF02186662

A. Taktikos, ASSOCIATION OF RETINOBLASTOMA WITH MENTAL DEFECT AND OTHER PATHOLOGICAL MANIFESTATIONS, British Journal of Ophthalmology, vol.48, issue.9, pp.495-498, 1964.
DOI : 10.1136/bjo.48.9.495

M. Taylor, C. Dehainault, L. Desjardins, and F. Doz, Genotype???phenotype correlations in hereditary familial retinoblastoma, Human Mutation, vol.41, issue.3, pp.284-293, 2007.
DOI : 10.1002/humu.20443

B. Thienpont, J. R. Vermeesch, and J. P. Fryns, 25??Mb deletion of 13q13.3???q21.31 in a patient without retinoblastoma, European Journal of Medical Genetics, vol.48, issue.3, pp.363-366, 2005.
DOI : 10.1016/j.ejmg.2005.05.008

K. H. To, S. Pajovic, B. L. Gallie, and B. L. Theriault, Regulation of p14ARF expression by miR-24: a potential mechanism compromising the p53 response during retinoblastoma development, BMC Cancer, vol.5, issue.6, p.69, 2012.
DOI : 10.1016/j.ccr.2004.05.025

J. Toguchida, T. L. Mcgee, J. C. Paterson, and J. R. Eagle, Complete Genomic Sequence of the Human Retinoblastoma Susceptibility Gene, Genomics, vol.17, issue.3, pp.535-543, 1993.
DOI : 10.1006/geno.1993.1368

F. Toledo and G. M. Wahl, Regulating the p53 pathway: in vitro hypotheses, in vivo veritas, Nature Reviews Cancer, vol.55, issue.12, pp.909-923, 2006.
DOI : 10.1002/gcc.20310

C. Uchida, S. Miwa, K. Kitagawa, and T. Hattori, Enhanced Mdm2 activity inhibits pRB function via ubiquitin-dependent degradation, The EMBO Journal, vol.6, issue.1, pp.160-169, 2005.
DOI : 10.1038/ncb1101-973

L. T. Vassilev, B. T. Vu, B. Graves, and D. Carvajal, In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2, Science, vol.303, issue.5659, pp.844-848, 2004.
DOI : 10.1126/science.1092472

J. A. Veltman and H. G. Brunner, De novo mutations in human genetic disease, Nature Reviews Genetics, vol.5, issue.8, pp.565-575, 2012.
DOI : 10.1016/j.jneumeth.2011.02.028

J. C. Venter, M. D. Adams, E. W. Myers, and P. W. Li, The Sequence of the Human Genome, Science, vol.291, issue.5507, pp.1304-1351, 2001.
DOI : 10.1126/science.1058040
URL : https://hal.archives-ouvertes.fr/hal-00465088

B. Vogelstein and K. W. Kinzler, Cancer genes and the pathways they control, Nature Medicine, vol.1, issue.8, pp.789-799, 2004.
DOI : 10.1038/sj.onc.1207130

T. Walsh, M. K. Lee, S. Casadei, and A. M. Thornton, Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing, Proceedings of the National Academy of Sciences, vol.107, issue.28, pp.12629-12633, 2010.
DOI : 10.1073/pnas.1007983107

J. Weber, S. Miserere, J. Champ, and R. Looten, High-throughput simultaneous detection of point mutations and large-scale rearrangements by CE, ELECTROPHORESIS, vol.24, issue.23, pp.4282-4288, 2007.
DOI : 10.1002/elps.200700010

W. Xiao and P. J. Oefner, Denaturing high-performance liquid chromatography: A review, Human Mutation, vol.18, issue.6, pp.439-474, 2001.
DOI : 10.1002/humu.1130

X. L. Xu, Y. Fang, T. C. Lee, and D. Forrest, Retinoblastoma Has Properties of a Cone Precursor Tumor and Depends Upon Cone-Specific MDM2 Signaling, Cell, vol.137, issue.6, pp.1018-1031, 2009.
DOI : 10.1016/j.cell.2009.03.051

H. Youssoufian and R. E. Pyeritz, Mechanisms and consequences of somatic mosaicism in humans, Nature Reviews Genetics, vol.99, issue.10, pp.748-758, 2002.
DOI : 10.1038/nrg906

C. L. Yu, M. A. Tucker, D. H. Abramson, and K. Furukawa, Cause-Specific Mortality in Long-Term Survivors of Retinoblastoma, JNCI Journal of the National Cancer Institute, vol.101, issue.8, pp.581-591, 2009.
DOI : 10.1093/jnci/djp046

M. Zeschnigk, S. Bohringer, E. A. Price, and Z. Onadim, A novel real-time PCR assay for quantitative analysis of methylated alleles (QAMA): analysis of the retinoblastoma locus, Nucleic Acids Research, vol.32, issue.16, p.125, 2004.
DOI : 10.1093/nar/gnh122

J. Zhang, C. A. Benavente, J. Mcevoy, and J. Flores-otero, A novel retinoblastoma therapy from genomic and epigenetic analyses, Nature, vol.70, issue.7381, pp.329-334, 2012.
DOI : 10.1038/nature10733

K. Zhang, I. Nowak, D. Rushlow, and B. L. Gallie, gene mutations in patients with retinoblastoma and association with phenotypic expression, Human Mutation, vol.3, issue.4, pp.475-484, 2008.
DOI : 10.1002/humu.20664

L. Zhu, Tumour suppressor retinoblastoma protein Rb: A transcriptional regulator, European Journal of Cancer, vol.41, issue.16, pp.2415-2427, 2005.
DOI : 10.1016/j.ejca.2005.08.009

C. Houdayer, M. Gauthier-villars, L. Castéra, F. Doz, and D. Stoppa-lyonnet, Genetic Counseling and Molecular Diagnosis, Retinoblastoma: An Update on Clinical, 2012.

D. Abramson, M. Mendelsohn, and C. Servodidio, Familial retinoblastoma, where and when?, Acta Ophthalmologica Scandinavica, vol.76, issue.3, pp.334-342, 1998.
DOI : 10.1034/j.1600-0420.1998.760316.x

P. Albrecht, B. Ansperger-rescher, and A. Schuler, Spectrum of gross deletions and insertions in theRB1 gene in patients with retinoblastoma and association with phenotypic expression, Human Mutation, vol.59, issue.5, pp.437-482, 2005.
DOI : 10.1002/humu.20234

J. Alonso, P. Garcia-miguel, and J. Abelairas, Spectrum of germline RB1 gene mutations in Spanish retinoblastoma patients: Phenotypic and molecular epidemiological implications, Human Mutation, vol.12, issue.5, pp.412-434, 2001.
DOI : 10.1002/humu.1117

C. Andreutti-zaugg, S. Rjiggo, and R. , Inhibition of nonsense-mediated messenger RNA decay in clinical samples facilitates detection of human MSH2 mutations with an in vivo fusion protein assay and conventional techniques, Cancer Res, vol.57, pp.3288-93, 1997.

O. Baud, V. Cormier-daire, and S. Lyonnet, Dysmorphic phenotype and neurological impairment in 22 retinoblastoma patients with constitutional cytogenetic 13q deletion, Clinical Genetics, vol.52, issue.6, pp.478-82, 1999.
DOI : 10.1002/(SICI)1097-0142(19960315)77:6<1206::AID-CNCR30>3.3.CO;2-Q

R. Bremner, D. Chen, and M. Pacal, The RB protein family in retinal development and retinoblastoma: new insights from new mouse models MDM2 as a modifier gene in retinoblastoma, Dev Neurosci J Natl Cancer Inst, vol.26, issue.102, pp.417-451, 2004.

V. Caux-moncoutier, L. Castera, and C. Tirapo, EMMA, a cost- and time-effective diagnostic method for simultaneous detection of point mutations and large-scale genomic rearrangements: application to BRCA1 and BRCA2 in 1,525 patients, Human Mutation, vol.42, issue.Suppl 2, 2010.
DOI : 10.1002/humu.21414
URL : https://hal.archives-ouvertes.fr/hal-00613913

C. Bnwang and J. , Coordinated regulation of life and death by RB, Nat Rev Cancer, vol.3, pp.130-138, 2003.

C. Mharlow and E. , The retinoblastoma tumour suppressor in development and cancer, Nat Rev Cancer, vol.2, pp.910-917, 2002.

D. Comings, A General Theory of Carcinogenesis, Proceedings of the National Academy of Sciences, vol.70, issue.12, pp.3324-3332, 1973.
DOI : 10.1073/pnas.70.12.3324

I. De-la-rosa-velazquez, H. Rincon-arano, and L. Benitez-bribiesca, Epigenetic Regulation of the Human Retinoblastoma Tumor Suppressor Gene Promoter by CTCF, Cancer Research, vol.67, issue.6, pp.2577-85, 2007.
DOI : 10.1158/0008-5472.CAN-06-2024

C. Dehainault, A. Lauge, and V. Caux-moncoutier, Multiplex PCR/liquid chromatography assay for detection of gene rearrangements: application to RB1 gene, Nucleic Acids Research, vol.32, issue.18, p.139, 2004.
DOI : 10.1093/nar/gnh137

C. Dehainault, D. Michaux, and S. Pages-berhouet, A deep intronic mutation in the RB1 gene leads to intronic sequence exonisation, European Journal of Human Genetics, vol.34, issue.4, pp.473-480, 1986.
DOI : 10.1038/sj.ejhg.5201787

C. Duponchel, D. Rocco, C. Cicardi, and M. , Rapid detection by fluorescent multiplex PCR of exon deletions and duplications in theC1 inhibitorgene of hereditary angioedema patients, Human Mutation, vol.33, issue.1, pp.61-70, 2001.
DOI : 10.1002/1098-1004(2001)17:1<61::AID-HUMU7>3.0.CO;2-9

O. Fletcher, D. Easton, and K. Anderson, Lifetime Risks of Common Cancers Among Retinoblastoma Survivors, JNCI Journal of the National Cancer Institute, vol.96, issue.5, pp.357-63, 2004.
DOI : 10.1093/jnci/djh058

F. Rlosekoot and M. , Mutation detection by denaturing gradient gel electrophoresis (DGGE), Hum Mutat, vol.3, pp.83-94, 1994.

S. Friend, R. Bernards, and S. Rogelj, A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma, Nature, vol.4, issue.6089, pp.643-649, 1986.
DOI : 10.1038/323643a0

R. Gaytmenn, D. Hildebrand, and D. Sweet, Determination of the sensitivity and specificity of sibship calculations using AmpF l STR Profiler Plus, International Journal of Legal Medicine, vol.116, issue.3, pp.161-165, 2002.
DOI : 10.1007/s00414-001-0273-8

J. Harbour, Molecular Basis of Low-Penetrance Retinoblastoma, Archives of Ophthalmology, vol.119, issue.11, pp.1699-704, 2001.
DOI : 10.1001/archopht.119.11.1699

J. Holbrook, G. Neu-yilik, and M. Hentze, Nonsense-mediated decay approaches the clinic, Nature Genetics, vol.90, issue.8, pp.801-809, 2004.
DOI : 10.1038/sj.embor.7400091

C. Houdayer, M. Gauthier-villars, and A. Lauge, mutations by DHPLC and QMPSF, Human Mutation, vol.52, issue.2, pp.193-202, 2004.
DOI : 10.1002/humu.10303

C. Houdayer, V. Moncoutier, and J. Champ, Enhanced Mismatch Mutation Analysis: Simultaneous Detection of Point Mutations and Large Scale Rearrangements by Capillary Electrophoresis, Application to BRCA1 and BRCA2, Methods Mol Biol, vol.653, pp.147-80, 2010.
DOI : 10.1007/978-1-60761-759-4_9

M. Johns, J. Paulus-thomas, and J. , Purification of human genomic DNA from whole blood using sodium perchlorate in place of phenol, Analytical Biochemistry, vol.180, issue.2, pp.276-284, 1989.
DOI : 10.1016/0003-2697(89)90430-2

M. Klutz, B. Dlohmann, and D. , A Parent-of-Origin Effect in Two Families with Retinoblastoma Is Associated with a Distinct Splice Mutation in the RB1 Gene, The American Journal of Human Genetics, vol.71, issue.1, pp.174-183, 2002.
DOI : 10.1086/341284

A. Knudson and J. , Mutation and Cancer: Statistical Study of Retinoblastoma, Proceedings of the National Academy of Sciences, vol.68, issue.4, pp.820-823, 1971.
DOI : 10.1073/pnas.68.4.820

K. Lele, P. Lsstallard, and H. , Chromosome deletion in a case of retinoblastoma, Annals of Human Genetics, vol.82, issue.2, pp.171-175, 1963.
DOI : 10.1016/S0140-6736(61)91978-X

D. Lohmann, B. Brandt, and W. Hopping, Distinct RB1 gene mutations with low penetrance in hereditary retinoblastoma, Human Genetics, vol.94, issue.4, pp.349-54, 1994.
DOI : 10.1007/BF00201591

L. Drgallie and B. , Retinoblastoma: revisiting the model prototype of inherited cancer, Am J Med Genet C Semin Med Genet, vol.129, pp.23-31, 2004.

S. Miller, D. Ddpolesky, and H. , A simple salting out procedure for extracting DNA from human nucleated cells, Nucleic Acids Research, vol.16, issue.3, p.1215, 1988.
DOI : 10.1093/nar/16.3.1215

D. Mitter, R. Ullmann, and A. Muradyan, Genotype???phenotype correlations in patients with retinoblastoma and interstitial 13q deletions, European Journal of Human Genetics, vol.146, issue.9, pp.947-958, 2011.
DOI : 10.1002/ajmg.1320290403

A. Moll, S. Imhof, and L. Bouter, Second primary tumors in patients with hereditary retinoblastoma: A register???based follow???up study, 1945???1994, International Journal of Cancer, vol.67, issue.4, pp.515-524, 1996.
DOI : 10.1002/(SICI)1097-0215(19960807)67:4<515::AID-IJC9>3.3.CO;2-9

A. Moll, S. Imhof, and A. Meeteren, At what age could screening for familial retinoblastoma be stopped? A register based study 1945-98, British Journal of Ophthalmology, vol.84, issue.10, pp.1170-1172, 2000.
DOI : 10.1136/bjo.84.10.1170

M. Magallie and B. , A simplified scheme for genetic counseling in retinoblastoma, J Pediatr Ophthalmol Strabismus, vol.24, pp.124-129, 1987.

Z. Onadim, A. Hogg, and P. Baird, Oncogenic point mutations in exon 20 of the RB1 gene in families showing incomplete penetrance and mild expression of the retinoblastoma phenotype., Proceedings of the National Academy of Sciences, vol.89, issue.13, pp.6177-81, 1992.
DOI : 10.1073/pnas.89.13.6177

M. Orita, Y. Suzuki, and T. Sekiya, Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction, Genomics, vol.5, issue.4, pp.874-883, 1989.
DOI : 10.1016/0888-7543(89)90129-8

S. Richter, K. Vandezande, and N. Chen, Sensitive and Efficient Detection of RB1 Gene Mutations Enhances Care for Families with Retinoblastoma, The American Journal of Human Genetics, vol.72, issue.2, pp.253-69, 2003.
DOI : 10.1086/345651

F. Sanchez-sanchez, C. Ramirez-castillejo, and D. Weekes, Attenuation of disease phenotype through alternative translation initiation in low-penetrance retinoblastoma, Human Mutation, vol.12, issue.2, pp.159-67, 2007.
DOI : 10.1002/humu.20394

J. Schouten, C. Mcelgunn, and R. Waaijer, Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification, Nucleic Acids Research, vol.30, issue.12, pp.57-134, 2002.
DOI : 10.1093/nar/gnf056

T. Sivakumaran, P. Shen, and D. Wall, gene in human and primates, Human Mutation, vol.13, issue.4, pp.396-409, 2005.
DOI : 10.1002/humu.20154

M. Taylor, C. Dehainault, and L. Desjardins, Genotype???phenotype correlations in hereditary familial retinoblastoma, Human Mutation, vol.41, issue.3, pp.284-93, 2007.
DOI : 10.1002/humu.20443

J. Weber, R. Looten, and C. Houdayer, Improving sensitivity of electrophoretic heteroduplex analysis using nucleosides as additives: Application to the breast cancer predisposition geneBRCA2, ELECTROPHORESIS, vol.23, issue.8, pp.1444-52, 2006.
DOI : 10.1002/elps.200500797

J. Weber, S. Miserere, and J. Champ, High-throughput simultaneous detection of point mutations and large-scale rearrangements by CE Denaturing high-performance liquid chromatography: A review, Electrophoresis Xiao WOefner PJ. Hum Mutat, vol.28, issue.17, pp.4282-4290, 2001.

M. Zeschnigk, S. Bohringer, and E. Price, A novel real-time PCR assay for quantitative analysis of methylated alleles (QAMA): analysis of the retinoblastoma locus, Nucleic Acids Research, vol.32, issue.16, p.125, 2004.
DOI : 10.1093/nar/gnh122

L. Zhu, Tumour suppressor retinoblastoma protein Rb: A transcriptional regulator, European Journal of Cancer, vol.41, issue.16, pp.2415-2442, 2005.
DOI : 10.1016/j.ejca.2005.08.009